Artículos por temáticas

Preclinical insights into gamma-tACS: foundations for clinical translation in neurodegenerative diseases

Sánchez-Garrido Campos G, Zafra ÁM, Estévez-Rodríguez M, Cordones I, Ruffini G, Márquez-Ruiz J.

Front Neurosci. 2025 Mar 12;19:1549230. doi: 10.3389/fnins.2025.1549230. eCollection 2025.

NFE2L1 as a central regulator of proteostasis in neurodegenerative diseases: interplay with autophagy, ferroptosis, and the proteasome

Khodadadi H, Łuczyńska K, Winiarczyk D, Leszczyński P, Taniguchi H.

Front Mol Neurosci. 2025 May 1;18:1551571. doi: 10.3389/fnmol.2025.1551571. eCollection 2025.

Imaging the enteric nervous system

Hazart D, Moulzir M, Delhomme B, Oheim M, Ricard C.

Front Neuroanat. 2025 Mar 12;19:1532900. doi: 10.3389/fnana.2025.1532900. eCollection 2025.

Research progress on paternal mitochondrial inheritance: An overview

Hu W, Zhang J, Wu Z, Wu Y, Hu Y, Hu X, Cao J.

Mitochondrion. 2025 May;82:102019. doi: 10.1016/j.mito.2025.102019. Epub 2025 Feb 28.

Selenium metabolism and selenoproteins function in brain and encephalopathy

Li N, Zhang Z, Shen L, Song G, Tian J, Liu Q, Ni J.

Sci China Life Sci. 2025 Mar;68(3):628-656. doi: 10.1007/s11427-023-2621-7. Epub 2024 Nov 12.

Sphingolipidoses: expanding the spectrum of α-synucleinopathies

Erskine D, Bronowska AK, Outeiro TF, Attems J.

J Neural Transm (Vienna). 2025 Apr 17. doi: 10.1007/s00702-025-02925-z. Online ahead of print.

Evaluation of DBS computational modeling methodologies using in-vivo electrophysiology in Parkinson's disease

Borgheai SB, Howell B, Isbaine F, Noecker AM, Opri E, Risk BB, McIntyre CC, Miocinovic S.

medRxiv [Preprint]. 2025 May 6:2025.05.05.25326314. doi: 10.1101/2025.05.05.25326314.

Role of Achyranthes aspera in neurodegenerative diseases: current evidence and future directions

Luo H, Wei S, Fu S, Han L.

Front Pharmacol. 2025 Apr 9;16:1511011. doi: 10.3389/fphar.2025.1511011. eCollection 2025.

The Neuroprotective Potential of Betalains: A Focused Review

Ştefănescu C, Voştinaru O, Mogoşan C, Crişan G, Balica G.

Plants (Basel). 2025 Mar 21;14(7):994. doi: 10.3390/plants14070994.

The investigation of peripheral inflammatory and oxidative stress biomarkers in dementia with Lewy Bodies, compared with Alzheimer's Disease, and mild cognitive impairment

Yu Y, Shen H, Qin Q, Wang J, Nie Y, Wen L, Tang Y, Qu M.

Neuroscience. 2025 Mar 5;568:209-218. doi: 10.1016/j.neuroscience.2024.12.057. Epub 2025 Jan 10.

Active group-based performing arts interventions in Parkinson's disease: an updated systematic review and meta-analysis

Barnish MS, Reynolds SE, Nelson-Horne RV.

BMJ Open. 2025 Apr 9;15(4):e089920. doi: 10.1136/bmjopen-2024-089920.

Racial Disparities in Parkinson Disease Clinical Phenotype, Management, and Genetics: Protocol for a Prospective Observational Study

Hall DA, Shulman JM, Singleton A, Bandres Ciga S, S Tosin MH, Ouyang B, Shulman L.

JMIR Res Protoc. 2025 Apr 7;14:e60587. doi: 10.2196/60587.

Case report -Cavernoma involving substantia nigra and nigrostriatal pathway as a rare cause of secondary parkinsonism with a 5 year follow up

Sathyanarayana S, Pasquini J, Ledingham D, Mitra D, Warren N, Pavese N.

Parkinsonism Relat Disord. 2025 Mar;132:107281. doi: 10.1016/j.parkreldis.2025.107281. Epub 2025 Jan 13.

[A case of anti-IgLON5 disease with recurrent respiratory failure]

Akamatsu S, Mizukami H, Kimura A, Shimohata T, Shiraishi M, Yamano Y.

Rinsho Shinkeigaku. 2025 Mar 27;65(3):218-223. doi: 10.5692/clinicalneurol.cn-002014. Epub 2025 Feb 27.

A framework for integrating artificial intelligence for clinical care with continuous therapeutic monitoring

Chen E, Prakash S, Janapa Reddi V, Kim D, Rajpurkar P.

Nat Biomed Eng. 2025 Apr;9(4):445-454. doi: 10.1038/s41551-023-01115-0. Epub 2023 Nov 6.